Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT studyANNALS OF THE RHEUMATIC DISEASESIF20.62007-02-0193OAAI
Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five yearsANNALS OF THE RHEUMATIC DISEASESIF20.61999-05-0124OAAI
Genotyping for disease associated HLA DR β1 alleles and the need for early joint surgery in rheumatoid arthritis:: a quantitative evaluationANNALS OF THE RHEUMATIC DISEASESIF20.61999-02-0120OAAI
Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective studyANNALS OF THE RHEUMATIC DISEASESIF20.61998-02-0199OAAI
Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritisANNALS OF THE RHEUMATIC DISEASESIF20.61997-07-0173OAAI
GOLD INDUCED APLASTIC-ANEMIA UNRESPONSIVE TO G-CSFANNALS OF THE RHEUMATIC DISEASESIF20.61993-06-012OAAI
SERUM INTERLEUKIN-6 LEVELS IN RHEUMATOID-ARTHRITIS - CORRELATIONS WITH CLINICAL AND LABORATORY INDEXES OF DISEASE-ACTIVITYANNALS OF THE RHEUMATIC DISEASESIF20.61993-03-01345OAAI
SERUM CONCENTRATIONS OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN PATIENTS WITH RHEUMATOID-ARTHRITIS - EFFECT OF 2ND LINE DRUGSANNALS OF THE RHEUMATIC DISEASESIF20.61993-01-0116OAAI
DOUBLE-BLIND, PLACEBO CONTROLLED-STUDY OF METRONIDAZOLE AS A DISEASE MODIFYING AGENT IN THE TREATMENT OF RHEUMATOID-ARTHRITISANNALS OF THE RHEUMATIC DISEASESIF20.61992-06-0110OAAI
PROSPECTIVE TRIAL COMPARING THE USE OF SULFASALAZINE AND AURANOFIN AS 2ND LINE DRUGS IN PATIENTS WITH RHEUMATOID-ARTHRITISANNALS OF THE RHEUMATIC DISEASESIF20.61992-04-0126OAAI
RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF INOSINE PRANOBEX IN RHEUMATOID-ARTHRITISANNALS OF THE RHEUMATIC DISEASESIF20.61990-05-0110OAAI
LEUCOPENIA DURING SULPHASALAZINE TREATMENT FOR RHEUMATOID-ARTHRITISANNALS OF THE RHEUMATIC DISEASESIF20.61989-06-0120OAAI
EFFECT OF SULFASALAZINE ON THE RADIOLOGICAL PROGRESSION OF RHEUMATOID-ARTHRITISANNALS OF THE RHEUMATIC DISEASESIF20.61987-05-0163OAAI
A 3 YEAR FOLLOW-UP OF PATIENTS ALLOCATED TO PLACEBO, OR ORAL OR INJECTABLE GOLD THERAPY FOR RHEUMATOID-ARTHRITISANNALS OF THE RHEUMATIC DISEASESIF20.61986-09-0128OAAI
SEATONE IN RHEUMATOID-ARTHRITIS - A 6-MONTH PLACEBO-CONTROLLED STUDYANNALS OF THE RHEUMATIC DISEASESIF20.61985-03-0122OAAI
DOES 2ND-LINE THERAPY AFFECT THE RADIOLOGICAL PROGRESSION OF RHEUMATOID-ARTHRITISANNALS OF THE RHEUMATIC DISEASESIF20.61984-02-0168OAAI
GOLD LEVELS PRODUCED BY TREATMENT WITH AURANOFIN AND SODIUM AUROTHIOMALATEANNALS OF THE RHEUMATIC DISEASESIF20.61983-10-0136OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向